Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Hall

Showing results (401-410 of 536) with videos related to

Pageof 54
Sort By:
International Journal of Cancer|August 28, 2020
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancerPik-Fang Kho, Frederic Amant, Daniela Annibali, et al.
Plos One|May 6, 2016
RAD51B in Familial Breast CancerLiisa M Pelttari, Sofia Khan, Mikko Vuorela, et al.
Breast Cancer Research : BCR|February 18, 2016
Genetic predisposition to ductal carcinoma in situ of the breastChristos Petridis, Mark N Brook, Vandna Shah, et al.
Scientific Reports|October 6, 2021
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosisMaria Escala-Garcia, Sander Canisius, Renske Keeman, et al.
Oncotarget|December 22, 2017
<i>PHIP</i> - a novel candidate breast cancer susceptibility locus on 6q14.1Xiang Jiao, Christos Aravidis, Rajeshwari Marikkannu, et al.
Carcinogenesis|December 12, 2013
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancerKristen S Purrington, Susan Slager, Diana Eccles, et al.
Scientific Reports|November 16, 2016
rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer riskJingjing Liu, Ivona Lončar, J Margriet Collée, et al.
Nature|May 29, 2007
Genome-wide association study identifies novel breast cancer susceptibility lociDouglas F Easton, Karen A Pooley, Alison M Dunning, et al.
Human Molecular Genetics|April 26, 2012
The role of genetic breast cancer susceptibility variants as prognostic factorsPeter A Fasching, Paul D P Pharoah, Angela Cox, et al.
Nature Communications|June 18, 2014
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapyJingmei Li, Linda S Lindström, Jia N Foo, et al.
Pageof 54

Showing results (401-410 of 536) with videos related to

Sort By:
Pageof 54
International Journal of Cancer|August 28, 2020
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancerPik-Fang Kho, Frederic Amant, Daniela Annibali, et al.
Plos One|May 6, 2016
RAD51B in Familial Breast CancerLiisa M Pelttari, Sofia Khan, Mikko Vuorela, et al.
Breast Cancer Research : BCR|February 18, 2016
Genetic predisposition to ductal carcinoma in situ of the breastChristos Petridis, Mark N Brook, Vandna Shah, et al.
Scientific Reports|October 6, 2021
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosisMaria Escala-Garcia, Sander Canisius, Renske Keeman, et al.
Oncotarget|December 22, 2017
<i>PHIP</i> - a novel candidate breast cancer susceptibility locus on 6q14.1Xiang Jiao, Christos Aravidis, Rajeshwari Marikkannu, et al.
Carcinogenesis|December 12, 2013
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancerKristen S Purrington, Susan Slager, Diana Eccles, et al.
Scientific Reports|November 16, 2016
rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer riskJingjing Liu, Ivona Lončar, J Margriet Collée, et al.
Nature|May 29, 2007
Genome-wide association study identifies novel breast cancer susceptibility lociDouglas F Easton, Karen A Pooley, Alison M Dunning, et al.
Human Molecular Genetics|April 26, 2012
The role of genetic breast cancer susceptibility variants as prognostic factorsPeter A Fasching, Paul D P Pharoah, Angela Cox, et al.
Nature Communications|June 18, 2014
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapyJingmei Li, Linda S Lindström, Jia N Foo, et al.
Pageof 54